Washington Trust Bank’s Edwards Lifesciences EW Stock Holding History

Washington Trust Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,767	Closed	-$112K	–	311
2019 Q1	$112K	Buy	1,767 +1,200	+212%	+$68.5K	0.02%	246
2018 Q4	$29K	Hold	567	–	–	﹤0.01%	395
2018 Q3	$33K	Sell	567 -240	-30%	-$11.7K	﹤0.01%	425
2018 Q2	$39K	Hold	807	–	–	0.01%	408
2018 Q1	$37K	Hold	807	–	–	0.01%	441
2017 Q4	$30K	Hold	807	–	–	﹤0.01%	492
2017 Q3	$29K	Buy	807 +567	+236%	+$21.6K	﹤0.01%	476
2017 Q2	$9K	Sell	240 -498	-67%	-$18.2K	﹤0.01%	545
2017 Q1	$23K	Buy	738 +399	+118%	+$12.5K	0.01%	483
2016 Q4	$11K	Buy	339 +30	+10%	+$972	﹤0.01%	554
2016 Q3	$12K	Buy	309 +15	+5%	+$565	﹤0.01%	534
2016 Q2	$10K	Buy	294 +54	+23%	+$1.85K	﹤0.01%	563
2016 Q1	$7K	Hold	240	–	–	﹤0.01%	611
2015 Q4	$6K	Hold	240	–	–	﹤0.01%	639
2015 Q3	$6K	Hold	240	–	–	﹤0.01%	661
2015 Q2	$6K	Hold	240	–	–	﹤0.01%	704
2015 Q1	$6K	Hold	240	–	–	﹤0.01%	718
2014 Q4	$5K	Hold	240	–	–	﹤0.01%	775
2014 Q3	$4K	Hold	240	–	–	﹤0.01%	754
2014 Q2	$3K	Hold	240	–	–	﹤0.01%	818
2014 Q1	$3K	Buy	+240	New	+$2.77K	﹤0.01%	774

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Washington Trust Bank's EW Position: Q2 2019 in Review

Washington Trust Bank sold out of Edwards Lifesciences (EW) in Q2 2019, closing a stake of 1,767 shares — an estimated $112K sold.

Washington Trust Bank first reported a position in EW in Q1 2014 and held it in 21 quarters. The position peaked at $112K in Q1 2019. 921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

Washington Trust Bank reported no remaining Edwards Lifesciences position as of Q2 2019 after selling out during the quarter.
Washington Trust Bank sold 1,767 Edwards Lifesciences shares in Q2 2019, an estimated $112K.
Washington Trust Bank first reported a position in Edwards Lifesciences in Q1 2014 and held it in 21 quarters.
Washington Trust Bank's Edwards Lifesciences position peaked at $112K in Q1 2019.
921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on Washington Trust Bank's 13F filing for Q2 2019, filed 26 Jul 2019.